Sarcomatoid Renal Cell Carcinoma

• CLINICAL_TRIALS trial_result · 2025-08-08
  Clinical Trial Update: ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) [Phase 2]

  Phase 2 study UNICAB evaluating cabozantinib in various non-clear cell renal cell carcinoma subtypes after immunotherapy has been completed.

• CLINICAL_TRIALS trial_result · 2024-04-25
  Clinical Trial Update: Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy [Phase 3]

  This Phase 3 clinical trial update reports results for nivolumab in localized renal cell carcinoma patients undergoing nephrectomy, with the…

• CLINICAL_TRIALS trial_result · 2022-06-07
  Clinical Trial Update: Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer [Phase 2]

  Phase 2 trial evaluating trebananib with or without other targeted therapies for advanced renal cell carcinoma has completed with results po…

• CLINICAL_TRIALS trial_result · 2022-02-16
  Clinical Trial Update: Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602) [Phase 2]

  Phase II trial investigating sequential single-agent nivolumab followed by combination ipilimumab plus nivolumab in metastatic or unresectab…

• CLINICAL_TRIALS trial_result · 2020-04-08
  Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer [Phase 2]

  Phase 2 trial results for Pazopanib hydrochloride in metastatic or recurrent kidney cancers have been posted after the study completed, incl…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2017-06-22
  Clinical Trial Update: Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma [Phase 2]

  Phase 2 trial evaluating capecitabine, gemcitabine, and bevacizumab in sarcomatoid renal cell carcinoma has completed and posted results in …

• CLINICAL_TRIALS trial_result · 2015-04-03
  Clinical Trial Update: Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma [Phase 2]

  A Phase 2 trial evaluating the combination of sunitinib and gemcitabine in sarcomatoid or poor-risk metastatic renal cell carcinoma has comp…

• CLINICAL_TRIALS trial_result · 2013-06-28
  Clinical Trial Update: Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer [Phase 1, Phase 2]

  A Phase 1/Phase 2 trial evaluating the combination of sorafenib tosylate and bevacizumab in advanced renal cell carcinoma, with results post…